✦ LIBER ✦

Pyrimethamine alone as prophylaxis for cerebral toxoplasmosis in patients with advanced HIV infection

✍ Scribed by H. Klinker; P. Langmann; E. Richter

Book ID: 105296427
Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 434 KB
Volume: 24
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01743370

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of Twice-Weekly Pyrimetham

Effectiveness of Twice-Weekly Pyrimethamine-Sulfadoxine as Primary Prophylaxis ofPneumocystis cariniiPneumonia and Toxoplasmic Encephalitis in Patients with Advanced HIV Infection

✍ D. Schürmann; F. Bergmann; H. Albrecht; J. Padberg; T. Wünsche; T. Grünewald; M. 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 73 KB

High predictive value ofToxoplasma gondi

High predictive value ofToxoplasma gondiiIgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis

✍ C. Hellerbrand; F. D. Goebel; R. Disko 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 383 KB

Double hepatitis B virus infection in a

Double hepatitis B virus infection in a patient with HIV/hepatitis C virus coinfection and ‘anti-HBc alone’ as serological pattern

✍ A. A. Wagner; V. Loustaud-Ratti; I. Chemin; P. Weinbreck; F. Denis; S. Alain 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 137 KB

Prevention of cryptococcosis in HIV-infe

Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis

✍ PT Cantey; DS Stephens; D Rimland 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

The Protease Inhibitor Transfer Study (P

The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load

✍ M Bickel; V Rickerts; C Stephan; V Jacobi; C Rottmann; B Dauer; A Carlebach; A T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Lamivudine therapy in patients undergoin

Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu

✍ McCaughan, Geoffrey W. ;Spencer, Jenean ;Koorey, David ;Bowden, Scott ;Bartholom 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 75 KB 👁 1 views

Recurrent hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality after liver transplantation. Recently, antiviral therapy, such as lamivudine, has become available for prophylaxis against HBV reactivation posttransplantation and for the treatment of HBV recurrent disease.